FGF23 and chronic kidney disease: CKD–MBD, involving disturbances in calcium, phosphate, parathyroid hormone (PTH), and fibroblast growth factor 23 (FGF23), facilitates arterial calcification and vascular stiffness, both of which correlate with increased cardiovascular mortality [18].